Organon (OGN) Capital Expenditures (2020 - 2026)

Organon's Capital Expenditures history runs 7 years deep, the most recent figure standing at $37.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 15.62% year-over-year to $37.0 million; the TTM figure through Mar 2026 stood at $167.0 million (up 3.73% YoY), while the FY2025 annual figure was $162.0 million, down 7.43% from the prior year.
• Capital Expenditures was $37.0 million for Q1 2026 at Organon, down from $45.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $79.0 million in Q4 2023 to a low of $32.0 million in Q2 2024.
• Historically, Capital Expenditures has averaged $48.3 million across 5 years, with a median of $46.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 57.78% in 2023, then tumbled 54.93% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $63.0 million in 2022, then advanced by 25.4% to $79.0 million in 2023, then slumped by 30.38% to $55.0 million in 2024, then declined by 18.18% to $45.0 million in 2025, then slipped by 17.78% to $37.0 million in 2026.
• The last three Capital Expenditures figures came in at $37.0 million (Q1 2026), $45.0 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.